#Antibody: Are you trying to enhance the efficacy of your antibodies? Dr Thomas Valerius, Division of Stem Cell Transplantation and Immunotherapy at the Christian-Albrechts University, addresses this problem for their anti-EGFR antibody in the video below.
This presentation was given at the 2011 European Antibody Congress, where Dr Valerius also covered:
- biomarker analysis for directed therapy and the affect this could have in patient selection
- The effect, if any, that activating maturations has on responsiveness to drugs
- Can mutations be used to predict resistance?
- Evaluating effector mechanisms
Do you want to find out more?